Arachidonic Acid

Global Arachidonic Acid Market to Reach US$413.2 Million by 2030

The global market for Arachidonic Acid estimated at US$294.6 Million in the year 2024, is expected to reach US$413.2 Million by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Powder Form, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$322.0 Million by the end of the analysis period. Growth in the Liquid Form segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$76.9 Million While China is Forecast to Grow at 8.6% CAGR

The Arachidonic Acid market in the U.S. is estimated at US$76.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$94.1 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Arachidonic Acid Market - Key Trends and Drivers Summarized

What Is Arachidonic Acid and Why Is It Important?

Arachidonic acid (ARA) is a polyunsaturated omega-6 fatty acid that plays a crucial role in the human body, particularly in the inflammatory response and cellular signaling processes. It is a key component of cell membranes and serves as a precursor for the synthesis of prostaglandins, thromboxanes, and leukotrienes, which are involved in various physiological functions such as blood clotting, immune response, and the regulation of blood pressure. ARA is predominantly found in animal-based foods, including meat, eggs, and fish, but it can also be synthesized from linoleic acid, another omega-6 fatty acid. In recent years, ARA has gained significant attention for its role in infant nutrition, as it is a vital component of breast milk and is crucial for the development of the brain and nervous system in infants. The importance of ARA in maintaining overall health and its critical function in growth and development has led to its inclusion in various dietary supplements and fortified foods.

How Is Arachidonic Acid Used in Nutritional and Pharmaceutical Products?

The use of arachidonic acid in nutritional and pharmaceutical products has expanded significantly, driven by growing awareness of its health benefits and the increasing demand for omega-6 fatty acid supplements. In the infant formula industry, ARA is often paired with docosahexaenoic acid (DHA), an omega-3 fatty acid, to mimic the composition of breast milk and support cognitive and visual development in infants. This combination has become a standard ingredient in many infant formulas worldwide. Beyond infant nutrition, ARA is also being incorporated into dietary supplements aimed at adults, particularly those focused on brain health, cognitive function, and athletic performance. In the pharmaceutical sector, ARA is being explored for its potential therapeutic applications, including its role in managing inflammatory conditions, autoimmune diseases, and cardiovascular health. The versatility of ARA as a bioactive compound has made it a valuable ingredient in a wide range of health products, and ongoing research continues to uncover new applications and benefits.

What Are the Key Trends and Developments in the Arachidonic Acid Market?

Several key trends and developments are shaping the arachidonic acid market, reflecting the evolving needs and preferences of consumers and advancements in biotechnology. One of the most significant trends is the increasing focus on plant-based and microbial sources of ARA, driven by the rising demand for vegetarian and vegan alternatives to animal-derived products. Advances in fermentation technology have enabled the production of ARA from non-animal sources, making it more accessible to a broader range of consumers. Another important trend is the growing emphasis on the purity and sustainability of ARA production, with manufacturers adopting environmentally friendly processes and ensuring that their products meet stringent quality standards. Additionally, there is a growing interest in the synergistic effects of ARA when combined with other bioactive compounds, such as DHA, leading to the development of innovative nutritional and therapeutic products. These trends are not only expanding the market for ARA but also driving innovation and differentiation among manufacturers.

What Factors Are Driving Growth in the Arachidonic Acid Market?

The growth in the arachidonic acid market is driven by several factors that are closely aligned with technological advancements, consumer behavior, and regulatory developments. Firstly, the increasing awareness of the importance of ARA in infant nutrition, particularly in brain and eye development, is propelling demand for ARA-enriched infant formulas, especially in emerging markets where infant nutrition is a critical concern. Secondly, the rise in health-conscious consumers seeking supplements for cognitive health, inflammation management, and athletic performance is expanding the market for ARA in adult dietary supplements. Thirdly, advancements in biotechnology, particularly in the production of ARA from sustainable and non-animal sources, are making ARA more accessible to a diverse consumer base, including vegetarians and vegans. Additionally, regulatory support for the use of ARA in food and pharmaceutical products, combined with the increasing prevalence of chronic inflammatory conditions, is driving the adoption of ARA across various sectors. These factors, coupled with ongoing research into the health benefits of ARA, are fueling the robust growth of the arachidonic acid market, positioning it as a critical component of modern nutrition and healthcare.

SCOPE OF STUDY:

The report analyzes the Arachidonic Acid market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Form (Powder, Liquid); Application (Infant Formula, Other Applications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Abcam PLC
• Ackerlon Co. Pte. Ltd.
• Acme Synthetic Chemicals
• Ataman Kimya A.S.
• Biorbyt
• Cabio
• Cambridge Isotope Laboratories, Inc. (CIL)
• Cayman Chemical Company
• Enzo Life Sciences, Inc.
• Laurent Pharmaceuticals, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.